These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 10759680)
1. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity. Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
4. Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. Pantuck AJ; Matherly J; Zisman A; Nguyen D; Berger F; Gambhir SS; Black ME; Belldegrun A; Wu L Hum Gene Ther; 2002 May; 13(7):777-89. PubMed ID: 11975845 [TBL] [Abstract][Full Text] [Related]
5. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer. Wang ZX; Bian HB; Yang JS; De W; Ji XH Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512 [TBL] [Abstract][Full Text] [Related]
8. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer. Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376 [TBL] [Abstract][Full Text] [Related]
9. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
11. Suicide gene therapy on LNCaP human prostate cancer cells. Yoshimura I; Suzuki S; Tadakuma T; Hayakawa M Int J Urol; 2001 Jul; 8(7):S5-8. PubMed ID: 11442669 [TBL] [Abstract][Full Text] [Related]
12. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model. Cheon J; Moon DG; Cho HY; Park HS; Kim JJ; Gardner TA; Kao C Int J Urol; 2002 May; 9(5):261-7. PubMed ID: 12060439 [TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia. Park HS; Cheon J; Cho HY; Ko YH; Bae JH; Moon DG; Kim JJ Gene Ther; 2003 Jul; 10(13):1129-34. PubMed ID: 12808443 [TBL] [Abstract][Full Text] [Related]
15. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells. Cao HQ; Meng XM; Liu DQ; Zhao XW; Ding JF Chin Med J (Engl); 2004 Oct; 117(10):1464-70. PubMed ID: 15498366 [TBL] [Abstract][Full Text] [Related]
16. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir. Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018 [TBL] [Abstract][Full Text] [Related]
17. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene. Li BJ; Zhang C; Yi YX; Hao Y; Liu XP; Ou QJ World J Gastroenterol; 2007 Aug; 13(29):4006-10. PubMed ID: 17663519 [TBL] [Abstract][Full Text] [Related]
18. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer. Kubo H; Gardner TA; Wada Y; Koeneman KS; Gotoh A; Yang L; Kao C; Lim SD; Amin MB; Yang H; Black ME; Matsubara S; Nakagawa M; Gillenwater JY; Zhau HE; Chung LW Hum Gene Ther; 2003 Feb; 14(3):227-41. PubMed ID: 12639303 [TBL] [Abstract][Full Text] [Related]
19. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer. Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964 [TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Couderc BC; de Neuville S; Douin-Echinard V; Serres B; Manenti S; Darbon JM; Malecaze F Curr Eye Res; 1999 Dec; 19(6):472-82. PubMed ID: 10550788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]